Press release
CooperVision DreamLite® Ortho-K Lenses Gain European Approval for Slowing Progression of Myopia
Expands World's Largest Portfolio of Evidence-Based Myopia Control Interventions to Provide Eye Care Professionals with Multiple Options SAN RAMON, Calif.,
About this update from The Cooper Companies, Inc.
[{"type":"text","content":"Expands World's Largest Portfolio of Evidence-Based Myopia Control Interventions to Provide Eye Care Professionals with Multiple Options\n\n\nSAN RAMON, Calif., May 25, 2021 /PRNewswire/ -- CooperVision Specialty EyeCare's Procornea DreamLite® night lenses have received European approval for slowing the progression of myopia in children and young adults. The popular orthokeratology contact lens is the latest CooperVision myopia control product to gain the CE Mark, joining EyeDream and Paragon CRT® ortho-k designs, MiSight® 1 day soft contact lenses, and SightGlass Vision Diffusion Optics Technology spectacle lenses.\nCooperVision has built the world's largest portfolio of evidence-based myopia control interventions. This provides eye care professionals (ECPs) with multiple approved options for addressing the global myopia epidemic, helping them tailor the approach to each child and family.\n\"Myopia's increasing frequency and prevalence is one of the most discussed issues in eye health. But conversation without action will not change the lives of the hundreds of millions of children affected by the issue. That sentiment is echoed by the World Council of Optometry, which recently passed a resolution advising optometrists to incorporate a standard of care for myopia management within their practices,\" said Dr. Juan Carlos Aragón, President, CooperVision Specialty EyeCare. \n\"Our commitments to innovations such as DreamLite® night lenses, providing broader access to optical interventions with scientifically-demonstrated outcomes, and investing in widespread education for eye care professionals and parents are examples why CooperVision continues to lead the myopia management category. The latest CE Mark will help ECPs communicate with even more confidence about DreamLite® lenses' ability to slow the progression of myopia.\" \nDreamLite® night lenses can be used for myopia control with children who have a refraction of -0.75 D to -5.00 D and a cylindrical refraction with a maximum of -2.50 D. A two-year study showed that DreamLite® night lenses reduced axial length growth by 63% percent among high myopes compared to the single vision spectacle lens control group—a total reduction of 0.32 mm.1 The lenses are currently available across Europe, the Middle East, and China. \nCooperVision products are used by thousands of ECPs across th...